1 terminated. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Terminated 1 |
Follow HIV-2 Infection: new trials by email Literature Review of HIV-2 Infection trials Research Report on HIV-2 Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RESIST-2: 2nd-line ART for HIV-2 Infection HIV-2 Genotypic Drug Resistance Testing using DBS, 2nd line ART ( Zidovudine 300mg BID + Lamivudine 150mg BID or Tenofovir DF 300mg QD + Lamividine 300mg QD or Emtricitabine 200mg QD + Lopinavir/Ritonavir 400/100mg BID), 2nd line ART (Tenofovir DF 300mg QD + Lamividine 300mg QD or Emtricitabine 200mg QD + Lopinavir/Ritonavir 400/100mg BID + Raltegravir 400mg BID ) - HIV-2 Infection | Not applicable | Terminated | University of Washington | 152 | 2018-07-04 | 2021-01-25 |
BID protein, human (1) · Darunavir (1) · Emtricitabine (1) · Lamivudine (1) · Lopinavir (1) · Raltegravir Potassium (1) · Ritonavir (1) · Tenofovir (1) · Zidovudine (1)
Senegal (1)
Geoffrey S Gottlieb, MD PhD (1)
R01AI120765 (1)